Molecular Tumor Board, Center for Personalized Cancer Therapy

Contact Us

Alice Coutinho, BS
Project Manager
Translational Research
acoutinho@ucsd.edu

Related Programs

Support Personalized Cancer Care

The MY ANSWER TO CANCER initiative aims to transform cancer therapy.

Give Now

Tumor boards are meetings where physicians caring for patients with cancer and other providers meet to discuss specific patients and advise one another on the best treatment plans.

Under the direction of Razelle Kurzrock, MD, UC San Diego Health System and Moores Cancer Center have initiated a new, leading-edge type of tumor board that discusses patients with all types of cancer whose tumors have been analyzed with advanced genomic diagnostic tests. This new Molecular Tumor Board, working with our Center for Personalized Cancer Therapy, enables us to translate the strong science at Moores Cancer Center into recommendations for individual patient treatments.

The Molecular Tumor Board includes expert physicians and world-class scientists, including medical oncologists, surgeons, radiation therapists, researchers, geneticists and pathologists. 

Board Moderators

Razelle Kurzrock, MD
Senior Deputy Director for Clinical Science
Director, Center for Personalized Cancer Therapy

Barbara Parker, MD
Deputy Director for Clinical Affairs

Richard Schwab, MD
Associate Clinical Professor, Hematology/Oncology

 

Tumor Board

The Molecular Tumor Board reviews a patient's information in order to discuss personalized cancer therapy. Pictured are, from left, co-moderator Barbara Parker, MD, deputy director for clinical affairs; moderator Razelle Kurzrock, MD, senior deputy director for clinical science and director of the Center for Personalized Cancer Therapy; co-moderator Richard Schwab, MD, associate clinical professor of hematology/oncology; Carl Hoh, MD, associate professor of radiology; and Brian Datnow, MD, clinical professor of pathology.

Tumor Board

The Molecular Tumor Board reviews a patient's medical information in order to discuss personalized cancer therapy options.